- World rank, all time
- #31,280 of 42,892
- Rank in France
- #1,761 of 2,321
- Research works
- 177 ▲ 33% vs 2013–17
- Citations
- 3.5k 19.6 per fractional work
- Top-10% rate
- 8.4% record average 16.5%
- Open access
- 43% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 2.9×. Every wedge is a field page.
- Health Professions 2.9×
- Medicine 2.8×
- Business, Management and Accounting 2.6×
- Nursing 1.2×
- Environmental Science 1.2×
- Immunology and Microbiology 1.1×
- Arts and Humanities 1.1×
- Earth and Planetary Sciences 0.9×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Decision Sciences 0.7×
- Mathematics 0.5×
- Economics, Econometrics and Finance 0.4×
- Social Sciences 0.3×
- Computer Science 0.3×
- Engineering 0.3×
- Materials Science 0.2×
- Physics and Astronomy 0.2×
- Chemistry 0.1×
- Agricultural and Biological Sciences 0.1×
- Neuroscience 0.1×
- Psychology 0.1×
Who are the top researchers at Lymphoma Study Association?
Ranked on the composite score, Bernard Phan lead among researchers whose main affiliation is Lymphoma Study Association.
- 1 Bernard Phan France · #483,206 worldwide 0 citations · 23 works
Which keywords describe research at Lymphoma Study Association?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Lymphoma, Rituximab, Prognostic Factors, PET Imaging, Classification, Molecular Profiling, Immunotherapy and Fuzzy Mathematics.
- Value Creation
- Social Innovation
- Mycosis Fungoides
- Cutaneous Lymphomas
- Therapeutic Targets
- Methotrexate
- Genomic Aberrations
- Prognostic Scoring System
- Inequalities
- Primary Care
- Diagnosis
- Chimeric Antigen Receptor
- Treatment
- Management
- Set Pair Analysis
- Fuzzy Mathematics
- Immunotherapy
- Molecular Profiling
- Prognostic Factors
- Rituximab
- Lymphoma
- Epidemiology
- Classification
- PET Imaging
- Public Health
- Risk Assessment
- Chemotherapy
- Radiotherapy
- CAR T Cells
- Leukemia
- Social Determinants of Health
- Healthcare Policy
- Strategic Alliances
- Chronic Lymphocytic Leukemia
- Guidelines
- Primary CNS Lymphoma
- Co-Creation
- Institutionalization
- Platform Competition
- Two-Sided Markets
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Lymphoma5▲ 66×4 topics
- Rituximab4▲ 62×3 topics
- Epidemiology3▲ 1.81×22 topics
- Prognostic Factors3▲ 16×7 topics
- Classification3▲ 15×1 topic
- Molecular Profiling3▲ 70×1 topic
- PET Imaging3▲ 41×3 topics
- Immunotherapy3▲ 8.8×11 topics
- Public Health2▲ 3.5×5 topics
- Fuzzy Mathematics2▲ 242×1 topic
- Risk Assessment2▲ 7.5×2 topics
- Set Pair Analysis2▲ 242×1 topic
- Chemotherapy2▲ 6.6×12 topics
- Management2▲ 5.4×9 topics
- Radiotherapy2▲ 11×6 topics
- Treatment2▲ 3.2×10 topics
- CAR T Cells2▲ 47×1 topic
- Chimeric Antigen Receptor2▲ 47×1 topic
- Leukemia2▲ 42×2 topics
- Diagnosis2▲ 3.7×11 topics
- Social Determinants of Health2▲ 15×2 topics
- Primary Care1▲ 8.0×4 topics
- Healthcare Policy1▲ 28×1 topic
- Inequalities1▲ 76×1 topic
- Strategic Alliances1▲ 40×2 topics
- Prognostic Scoring System1▲ 63×2 topics
- Chronic Lymphocytic Leukemia1▲ 49×1 topic
- Genomic Aberrations1▲ 49×1 topic
- Guidelines1▲ 5.0×4 topics
- Methotrexate1▲ 155×1 topic
- Primary CNS Lymphoma1▲ 155×1 topic
- Therapeutic Targets1▲ 15×2 topics
- Co-Creation1▲ 48×1 topic
- Cutaneous Lymphomas1▲ 118×1 topic
- Institutionalization1▲ 23×2 topics
- Mycosis Fungoides1▲ 118×1 topic
- Platform Competition1▲ 78×1 topic
- Social Innovation1▲ 13×1 topic
- Two-Sided Markets1▲ 78×1 topic
- Value Creation1▲ 55×1 topic
Which research topics does Lymphoma Study Association publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Research studies in Vietnam, CAR-T cell therapy research and Healthcare Systems and Practices.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 3 works
- 2 Research studies in Vietnam Ecology 2 works
- 3 CAR-T cell therapy research Oncology 2 works
- 4 Healthcare Systems and Practices General Health Professions 1 works
- 5 CNS Lymphoma Diagnosis and Treatment Neurology 1 works
- 6 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 7 Social Sciences and Governance Urban Studies 1 works
- 8 Cutaneous lymphoproliferative disorders research Dermatology 1 works
- 9 Service and Product Innovation Marketing 1 works
- 10 Digital Platforms and Economics Strategy and Management 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Lymphoma Study Association's research output changed?
Output in 2018–2022 was 33% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Pierre-Bénite
- Hôpital Lyon Sud
- Centre de Recherche en Nutrition Humaine Rhône-Alpes
- The Lymphoma Academic Research Organisation
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.